COPD & Allergy Flashcards
pathophys of COPD
not fully reversible airflow limitation; chronic lung and airway inflammation w mucus hypersecretion and gas exchange abnormalities
Treatment strategies for COPD
B2-R agonist anti-ACh inhalers bronchodilators long-acting inhaled bronchodilators Combined therapy of bronchodilators
ADR of inhaled corticosteroids in COPD
increased risk of osteoporosis with extended use
roflumilast
oral PDE4 inhibitor
used in pts with severe COPD with bronchitis and history of exacerbation to dec exacerbations
ADR roflumilast
nausea, diarrhea, insomnia, weight loss
interaction with CYP 3A4 inhibitors and inducers
Meds to use for COPD exacerbations
inhaled bronchodilators (B2-ag or anti-ACh), theophylline, systemic corticosteroids, +/- roflumilast antibiotics if infection present
Tx of COPD
stop smoking, bronchodilators, steroids (?), antibacterials (frequent infection)
etiology of allergic rhinitis
Seasonal (SAR) - repetitive predictable symptoms in spring/fall, acute and triggered by allergens
perennial (PAR) - chronic, triggered by non-seasonal allergens
*Can have both
Sx of allergic rhinitis
ocular: venous congestion -> “allergic shiners”, pruritus, watery red eyes or SAR conjunctivitis
Nasal: clear rhinorrhea, sneezing, congestion, pruritus, post-nasal drip
systemic: fatigue, irritability, cognitive impairment
Drug categories for allergic rhinitis
Anti-histamines/ H1-R antagonist
decongestants
corticosteroids
MOA of antihistamines
antagonize capillary permeability, wheal and flare formation, pruritus
anti-ACh properties reduced nasal, salivary, lacrimal gland secretions
Brompheniramine
1st gen oral antihistamine
chlorpheniramine
1st gen oral antihistamine
clemastine
1st gen oral antihistamine
diphenhydramine
1st gen oral antihistamine
1st vs. 2nd gen oral antihistamines
1st gen penetrates CNS -> sedation/ cognitive impairment; OTC
2nd gen Rx and OTC; peripherally selective = “non-sedating”
cetirizine
2nd gen oral antihistamine